Index RUT
P/E -
EPS (ttm) -0.13
Insider Own 1.10%
Shs Outstand 50.77M
Perf Week -0.99%
Market Cap 3.42B
Forward P/E 88.72
EPS next Y 0.76
Insider Trans -15.95%
Shs Float 50.44M
Perf Month -2.40%
Income -6.09M
PEG -
EPS next Q -0.05
Inst Own 100.78%
Short Float 6.82%
Perf Quarter -1.87%
Sales 366.38M
P/S 9.33
EPS this Y 433.37%
Inst Trans 3.12%
Short Ratio 3.48
Perf Half Y 24.35%
Book/sh 12.56
P/B 5.34
EPS next Y 88.93%
ROA -0.88%
Short Interest 3.44M
Perf Year 16.85%
Cash/sh 6.76
P/C 9.91
EPS next 5Y -
ROE -1.01%
52W Range 47.59 - 69.68
Perf YTD 7.75%
Dividend Est. -
P/FCF -
EPS past 5Y 36.15%
ROI -0.92%
52W High -3.77%
Beta 0.60
Dividend TTM -
Quick Ratio 8.98
Sales past 5Y 541.82%
Gross Margin 72.46%
52W Low 40.89%
ATR (14) 0.44
Dividend Ex-Date -
Current Ratio 10.73
EPS Y/Y TTM 90.17%
Oper. Margin -1.29%
RSI (14) 36.77
Volatility 0.50% 0.53%
Employees 797
Debt/Eq 0.04
Sales Y/Y TTM 33.86%
Profit Margin -1.66%
Recom 2.83
Target Price 71.44
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q 908.33%
Payout -
Rel Volume 0.51
Prev Close 67.20
Sales Surprise 2.24%
EPS Surprise 101.55%
Sales Q/Q 27.72%
Earnings Feb 28 AMC
Avg Volume 986.73K
Price 67.05
SMA20 -1.73%
SMA50 -1.46%
SMA200 11.12%
Trades
Volume 507,604
Change -0.22%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-09-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Jul-19-23 Initiated
Robert W. Baird
Outperform
$69
Jul-13-23 Initiated
KeyBanc Capital Markets
Overweight
$70
May-23-23 Initiated
CL King
Buy
$75
Apr-14-23 Initiated
Mizuho
Buy
$75
Mar-24-23 Upgrade
Needham
Hold → Buy
$71
Oct-21-22 Initiated
RBC Capital Mkts
Outperform
$85
Oct-12-22 Initiated
Jefferies
Hold
$75
Oct-10-22 Downgrade
Needham
Buy → Hold
Apr-06-22 Initiated
Wolfe Research
Outperform
$69
Mar-02-22 Resumed
BofA Securities
Buy
$70
Jul-12-21 Initiated
Barclays
Overweight
$74
Jun-28-21 Reiterated
Needham
Buy
$72 → $78
Nov-05-20 Reiterated
Needham
Buy
$57 → $62
Oct-23-20 Initiated
Guggenheim
Buy
$77
Sep-02-20 Initiated
Robert W. Baird
Outperform
$52
Aug-07-20 Reiterated
Needham
Buy
$48 → $57
Jan-08-20 Initiated
SunTrust
Buy
$38
Nov-01-19 Initiated
Piper Jaffray
Overweight
$39
Oct-21-19 Initiated
Barclays
Overweight
$43
Show Previous Ratings
Mar-29-24 12:00PM
Mar-22-24 04:01PM
Mar-21-24 04:54PM
Mar-15-24 08:53AM
Mar-14-24 06:00AM
04:01PM
Loading…
Feb-29-24 04:01PM
Feb-28-24 07:01PM
05:40PM
04:41PM
(Associated Press Finance)
04:01PM
Feb-02-24 09:09PM
Jan-31-24 06:30AM
Jan-29-24 11:02PM
Jan-25-24 08:07AM
Jan-23-24 02:45PM
03:07PM
Loading…
Jan-10-24 03:07PM
Jan-08-24 07:38PM
11:28AM
07:58AM
(The Wall Street Journal)
07:00AM
07:00AM
07:00AM
Dec-27-23 04:01PM
Nov-20-23 09:55AM
Nov-06-23 12:00PM
Nov-01-23 06:00AM
Oct-31-23 09:27AM
Oct-30-23 05:55PM
05:40PM
04:28PM
(Associated Press Finance)
04:01PM
Loading…
04:01PM
Oct-26-23 10:02AM
Oct-23-23 10:00AM
Oct-16-23 10:23AM
Oct-14-23 01:15PM
Oct-11-23 11:42AM
Oct-02-23 06:00AM
Sep-22-23 11:47AM
Sep-11-23 11:47AM
Aug-25-23 06:00AM
Aug-21-23 06:00AM
Jul-28-23 12:46PM
Jul-27-23 05:25PM
04:18PM
04:01PM
Jun-29-23 06:00AM
May-31-23 10:27AM
May-25-23 09:28AM
May-16-23 02:45AM
May-08-23 09:06AM
May-01-23 05:15PM
04:07PM
04:01PM
Apr-25-23 06:00AM
Apr-24-23 06:00AM
Apr-17-23 03:54PM
Apr-10-23 06:00AM
Mar-29-23 06:00AM
Mar-07-23 06:00AM
Mar-04-23 07:39AM
Mar-01-23 05:25PM
04:01PM
Feb-25-23 02:14PM
Feb-22-23 10:00AM
Feb-08-23 04:30PM
Jan-31-23 06:00AM
Jan-19-23 06:43AM
Jan-12-23 09:19AM
07:21AM
Jan-11-23 06:00AM
Dec-23-22 12:58PM
Dec-22-22 09:03AM
Dec-21-22 06:00AM
Dec-19-22 09:40AM
Dec-13-22 12:40PM
06:00AM
Dec-02-22 09:40AM
07:10AM
Nov-18-22 06:00AM
Nov-16-22 11:06AM
09:40AM
Nov-07-22 12:52PM
Nov-01-22 12:35PM
Oct-31-22 05:15PM
04:01PM
09:40AM
Oct-24-22 10:00AM
Oct-13-22 09:40AM
Oct-09-22 10:20AM
Sep-26-22 09:40AM
Sep-12-22 09:15AM
Sep-08-22 06:00AM
Sep-07-22 09:40AM
Aug-22-22 09:40AM
Aug-18-22 06:00AM
Aug-17-22 06:00AM
Aug-08-22 12:00PM
Aug-05-22 04:34PM
Aug-04-22 09:40AM
Aug-02-22 11:13PM
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Noblett Karen Chief Medical Officer Jan 31 '24 Option Exercise 0.00 27,500 0 45,716 Feb 02 05:59 PM Sama Rinda Chief Operating Officer Jan 31 '24 Option Exercise 0.00 28,000 0 83,854 Feb 02 06:00 PM Woock John EVP, Chief Mktg/Strtgy Officer Jan 31 '24 Option Exercise 0.00 28,000 0 93,302 Feb 02 05:59 PM Ford Alfred J Jr Chief Commercial Officer Jan 31 '24 Option Exercise 0.00 25,500 0 60,065 Feb 02 05:59 PM COHEN RAYMOND W Chief Executive Officer Jan 31 '24 Option Exercise 0.00 63,400 0 223,996 Feb 02 05:59 PM Keese Kari Leigh Chief Financial Officer Jan 31 '24 Option Exercise 0.00 6,167 0 46,812 Feb 02 05:59 PM COHEN RAYMOND W Chief Executive Officer Jan 31 '24 Sale 67.74 35,161 2,381,662 188,835 Feb 02 05:59 PM Ford Alfred J Jr Chief Commercial Officer Jan 31 '24 Sale 67.74 16,615 1,125,432 43,450 Feb 02 05:59 PM Woock John EVP, Chief Mktg/Strtgy Officer Jan 31 '24 Sale 67.74 15,899 1,076,933 77,403 Feb 02 05:59 PM Noblett Karen Chief Medical Officer Jan 31 '24 Sale 67.74 11,288 764,603 34,428 Feb 02 05:59 PM Keese Kari Leigh Chief Financial Officer Jan 31 '24 Sale 67.74 3,489 236,331 43,323 Feb 02 05:59 PM Noblett Karen Chief Medical Officer Jan 08 '24 Sale 69.00 15,999 1,103,961 18,216 Jan 10 08:00 PM Noblett Karen Chief Medical Officer Dec 28 '23 Sale 63.28 7,051 446,177 34,215 Dec 28 07:17 PM Noblett Karen Chief Medical Officer Dec 26 '23 Sale 63.00 949 59,787 41,266 Dec 28 07:17 PM Dearen Danny L. President & CFO Sep 29 '23 Option Exercise 0.00 11,250 0 31,452 Oct 03 07:37 PM Dearen Danny L. President & CFO Sep 29 '23 Sale 56.87 7,675 436,490 23,777 Oct 03 07:37 PM Ford Alfred J Jr Chief Commercial Officer Aug 15 '23 Sale 62.34 14,769 920,671 34,565 Aug 17 07:47 PM Ford Alfred J Jr Chief Commercial Officer Jul 28 '23 Sale 62.01 1,500 93,021 49,334 Aug 01 08:01 PM Dearen Danny L. President & CFO May 26 '23 Sale 49.46 7,999 395,646 9,202 May 31 08:01 PM Dearen Danny L. President & CFO Apr 21 '23 Option Exercise 14.19 13,208 187,422 37,201 Apr 25 08:06 PM Dearen Danny L. President & CFO Apr 21 '23 Sale 60.21 20,000 1,204,137 17,201 Apr 25 08:06 PM Dearen Danny L. President & CFO Apr 20 '23 Option Exercise 14.19 2,001 28,394 25,994 Apr 24 08:35 PM Dearen Danny L. President & CFO Apr 20 '23 Sale 60.01 2,001 120,073 23,993 Apr 24 08:35 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite